You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Innovative Trajectory Solutions for Rapid Global Military Response

    SBC: SPACEWORKS ENTERPRISES INC            Topic: AF05192

    SpaceWorks proposes to continue development and advancement of its novel QuickShot trajectory optimization software suite. A number of new modeling capabilities of value when simulating advanced military systems will be implemented. Additionally, a variety of case studies and applications that will showcase and demonstrate utilization of these new features will be conducted.

    SBIR Phase II 2019 Department of DefenseAir Force
  2. A Novel, Nanostructured, Metal-Organic Frameworks-Based Pretreatment Technology for the Remediation of PFAS in Industrial Wastewater

    SBC: FRAMERGY INC            Topic: 18NCER1C

    Per- and polyflouralkyl substances, otherwise known as PFAS, are a large group of chemicals including perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). These chemicals have a large variety of uses globally. Remediation of PFAS has gained importance due to their environmental persistence and toxicity. Water treatment methods must combine multiple strategies to be effective, as PF ...

    SBIR Phase I 2019 Environmental Protection Agency
  3. A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector

    SBC: FRAMERGY INC            Topic: 18NCERP2

    To reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logisticalsystem requires natural gas gathering lines, processing facilities,product storage tanks and Jots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermitte ...

    SBIR Phase II 2019 Environmental Protection Agency
  4. Mobile Health Point-of-Care Diagnostics for Tuberculosis

    SBC: B & W TEK INC            Topic: NIAID

    TuberculosisTBkilled an estimatedmillion people in the world inOverof the mortalities associated with this deisease occurred in regions of the world where access to reliable TB testing and other suppotive infrastructure is severely limitedUntil there are pivotal technological innovations in the diagnosis of TB for point of carePOCapplicationthe ambitious goals of the WHO s End TB strategyareductio ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Development of Membrane Anchored Cytokines as Novel Vaccine Adjuvants for the Elderly

    SBC: METACLIPSE THERAPEUTICS CORP            Topic: NIAID

    lnterleukinILand granulocyte macrophage colony stimulating factorGM CSFare endogenous immune activatorsEarlier studies using soluble ILand GM CSF as vaccine adjuvants were unsuccessful due to toxicity or suboptimal responseWe developed versions of ILand GM CSF with a glycosylated phosphatidylinositolGPIanchor added at the carboxyl terminusallowing incorporation into lipid bilayers such as in influ ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Creating Antibodies to Enable the Study of Mycobacterium Tuberculosis Infections in Guinea Pigs

    SBC: GLYCOSCIENTIFIC, L.L.C.            Topic: NIAID

    Tuberculosis is a persistent infectious disease that threatens the health of people and numerous mammalian species throughout the worldMonitoring of Mycobacterium tuberculosisMtbinfections in animal models has often relied on host mortalitybacterial loadsand qualitative assessment of pathology at necropsyThese are blunt toolslargely unrelated to the markers used for diagnosis and epidemiological s ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. DEVELOP NEW COMMERCIALLY VIABLE DEVICES, TOOLS, TECHNOLOGIES OR INTEGRATED SYSTEMS FOR DRUG DETECTION AND DEACTIVATION TO DETER OPIOID THEFT IN HOSPITALS.

    SBC: B & W TEK INC            Topic: NIDA

    The Contractorwill use modern technology to develop a fully integratedcommercially viable device for controlled pharmaceutical drug detectiondeactivationand disposal to ensure compliance with DEA regulations and deter opioid theft

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Development of mitoNEET agonists for the treatment of stroke

    SBC: MODULATION THERAPEUTICS, INC.            Topic: 102

    ABSTRACT Stroke is the fifth leading cause of death and the leading cause of disability in the United StatesThere remains a critical need for innovative therapeutic approaches that can successfully prevent or reverse brain injury following strokeDysfunction of the mitochondrial biochemistry following ischemic stroke and reperfusion injury contributes to significant neuronal cell losshoweverthe dev ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Novel sanitizer/disinfectants against viral infections with long-lasting effect

    SBC: CAMELLIX, LLC            Topic: NIAID

    AbstractNorovirus is the most common cause of acute gastroenteritis in the United States, associated annually with 19-21 million illnesses, 56,000-71,000 hospitalizations and 570-800 deaths (US CDC, Overview about Norovirus). Norovirus is one of the nonenveloped viruses that are resistant to alcohol sanitization. According to US CDC Guidelines for the Prevention and Control of Norovirus Gastroente ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. A Microscale Platform for Augmentation of Cell Transduction (MPACT) to Enhance Ex Vivo Gene Transfer

    SBC: EXPRESSION THERAPEUTICS, LLC            Topic: NHLBI

    PROJECT SUMMARY ABSTRACT Recent advances in clinical gene therapy highlight the need for improved lentiviral vectorLVand adenoassociated viralAAVvector manufacture and utilization efficiencies for enhanced therapeutics outcomesExpression Therapeutics in collaboration with Emory University are developing a microfluidicFluidictechnology based solution that overcomes the mass transport and diffusion ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government